NasdaqCM - Delayed Quote • USD
Aptorum Group Limited (APM)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:31 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-11,598.76
-12,318.97
-14,651.63
-15,931.91
Investing Cash Flow
292.22
2,444.90
16,507.04
1,842.16
Financing Cash Flow
4,581.13
6,625.46
2,780.73
12,421.93
End Cash Position
470.64
5,012.88
8,261.49
3,625.36
Interest Paid Supplemental Data
158.85
64.74
273.16
131.55
Capital Expenditure
-39.34
-186.92
-137.78
-161.31
Issuance of Capital Stock
1,575.56
5.36
4,000.00
17,497.43
Issuance of Debt
6,000.00
6,500.00
3,500.00
1,000.00
Repayment of Debt
-3,022.44
-49.36
-5,543.51
-5,360.40
Free Cash Flow
-11,638.10
-12,505.88
-14,789.41
-16,093.23
12/31/2020 - 12/18/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVTX Avalo Therapeutics, Inc.
14.20
+9.23%
RANI Rani Therapeutics Holdings, Inc.
6.99
+4.48%
BNTC Benitec Biopharma Inc.
6.72
-2.04%
OCEA Ocean Biomedical, Inc.
1.4150
-4.39%
CERO CERo Therapeutics Holdings, Inc.
1.4559
+7.84%
NKGN NKGen Biotech, Inc.
1.7100
-7.57%
RLYB Rallybio Corporation
1.5800
-9.20%
ALRN Aileron Therapeutics, Inc.
4.9300
+3.79%
PALI Palisade Bio, Inc.
6.35
+7.26%
CADL Candel Therapeutics, Inc.
6.05
+2.37%